About
Cala Health is a bioelectronic medicine company that specializes in wearable neuromodulation therapies. Originating from Stanford University’s Neuromuscular Biomechanics laboratory, the company develops non-invasive, prescription wearable devices aimed at treating chronic neurological conditions, particularly essential tremor and Parkinson’s disease. The flagship product, Cala kIQ™, is an FDA-approved wearable device that utilizes Transcutaneous Afferent Patterned Stimulation (TAPS) therapy. This technology stimulates nerves in the skin to help reduce hand tremors, offering an alternative or complementary option to medication. Designed for convenience, the device typically requires a 40-minute session and collects data to assist patients and physicians in monitoring treatment progress. Cala Health is dedicated to improving the quality of life and independence for individuals with chronic conditions. The company is expanding its technology platform to address additional chronic diseases in neurology, cardiology, and psychiatry. Headquartered in the San Francisco Bay Area, Cala Health is supported by prominent investors in the healthcare and technology sectors.
Technologies
Keywords
Company Information
-
Employees 95
-
Founded 2014
-
Annual Revenue $11300000
-
Total Funding $232770834
Location
1800 Gateway Dr, San Mateo, California, United States, 94404-2400
